World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
51823
World Ranking
7532
National Ranking
3930

Mark A. Espeland publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark A. Espeland sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 657 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark A. Espeland D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Espeland sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1996 - Fellow of the American Statistical Association (ASA)

Overview

Mark A. Espeland is affiliated with Wake Forest University in the United States. Their research primarily focuses on medicine, with particular attention to subfields including health, toxicology and mutagenesis, psychiatry and mental health, cardiology and cardiovascular medicine, physiology, and endocrinology, diabetes and metabolism.

The scientist's work spans several main topics in health and aging research. These topics include:

  • Dementia and Cognitive Impairment Research
  • Air Quality and Health Impacts
  • Frailty in Older Adults
  • Nutrition and Health in Aging
  • Health, Environment, Cognitive Aging
  • Noise Effects and Management
  • Blood Pressure and Hypertension Studies

Mark A. Espeland has coauthored numerous publications with frequent collaborators such as Kathleen M. Hayden, Stephen R. Rapp, Susan M. Resnick, Margaret Gatz, and Jiu-Chiuan Chen. Their research has appeared extensively in a variety of academic venues.

Prominent publication venues for this scientist include:

  • Alzheimer's & Dementia
  • Innovation in Aging
  • UNC Libraries
  • The Journals of Gerontology Series A
  • bioRxiv (Cold Spring Harbor Laboratory)

Selected recent papers authored or coauthored by Mark A. Espeland are:

  • "Physical Rehabilitation for Older Patients Hospitalized for Heart Failure," 2021, New England Journal of Medicine
  • "World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia," 2020, Alzheimer's & Dementia
  • "Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk," 2020, Circulation
  • "A practical solution to pseudoreplication bias in single-cell studies," 2021, Nature Communications
  • "The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans," 2020, Alzheimer's & Dementia

Mark A. Espeland was recognized as a Fellow of the American Statistical Association (ASA) in 1996.

Best Publications

  • Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

    R. R. Wing;P. Bolin;F. L. Brancati;G. A. Bray

  • Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

    Valery T. Miller;John LaRosa;Vanessa Barnabei;Craig Kessler

  • Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.

    Rena R. Wing;Judy L. Bahnson;George A. Bray;Jeanne M. Clark

  • Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons: A Randomized Controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE)

    Paul K. Whelton;Lawrence J. Appel;Mark A. Espeland;William B. Applegate

  • Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial

    Marco Pahor;Jack M. Guralnik;Jack M. Guralnik;Walter T. Ambrosius;Steven Blair

  • Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes: One-Year Results of the Look AHEAD Trial

    Mark Espeland;Xavier Pi-Sunyer;George Blackburn;Frederick L. Brancati

  • Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Stephen R. Rapp;Mark A. Espeland;Sally A. Shumaker;Victor W. Henderson

  • Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

    C D Furberg;H P Adams;W B Applegate;R P Byington

  • Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

    Donna H Ryan;Mark A Espeland;Gary D Foster;Steven M Haffner

  • Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.

    Mark A. Espeland;Stephen R. Rapp;Sally A. Shumaker;Robert Brunner

  • Metformin as a Tool to Target Aging.

    Nir Barzilai;Jill P. Crandall;Stephen B. Kritchevsky;Mark A. Espeland

  • Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study.

    Marco Pahor;Steven N. Blair;Mark Espeland;Roger Fielding

  • Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.

    Timothy E. Craven;Jacqueline E. Ryu;Mark A. Espeland;Frederic R. Kahl

  • Evaluation of the azoospermic patient.

    Jonathan P. Jarow;Mark A. Espeland;Mark A. Espeland;Larry I. Lipshultz;Larry I. Lipshultz

  • Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

    Howard L. Judd;Irma Mebane-Sims;Claudine Legault;Carol Wasilauskas

  • Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials

    Joann E. Manson;Aaron K. Aragaki;Jacques E. Rossouw;Garnet L. Anderson

  • Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.

    Julio Rosenstock;Steven E. Kahn;Odd Erik Johansen;Bernard Zinman;Bernard Zinman

  • The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

    Jingzhong Ding;Fang Chi Hsu;Tamara B. Harris;Yongmei Liu

  • Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial.

    Kaycee M. Sink;Mark A. Espeland;Cynthia M. Castro;Timothy Church

  • Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women: Women’s Health Initiative Memory Study

    Mark A. Espeland;Stephen R. Rapp;Sally A. Shumaker;Robert Brunner

Frequent Co-Authors

Susan M. Resnick
Susan M. Resnick National Institutes of Health
JoAnn E. Manson
JoAnn E. Manson Harvard Medical School
Karen C. Johnson
Karen C. Johnson University of Tennessee Health Science Center
Rena R. Wing
Rena R. Wing Brown University
William C. Knowler
William C. Knowler National Institutes of Health
Cora E. Lewis
Cora E. Lewis University of Alabama at Birmingham
Marcia L. Stefanick
Marcia L. Stefanick Stanford University
Laura D. Baker
Laura D. Baker Wake Forest University
Jeff D. Williamson
Jeff D. Williamson Wake Forest University
Helena C. Chui
Helena C. Chui University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open new opportunities for those interested in healthcare professions beyond traditional medical education. Accelerated msn psychiatric np programs allow nurses to quickly advance into specialized mental health roles, meeting the growing demand for psychiatric care.

Interested in the management side of healthcare? A bachelors in healthcare administration is a flexible degree, perfect for those seeking leadership positions in hospitals, clinics, or public health organizations.

Graduate degrees such as the cheapest mha programs offer professionals a cost-effective path to advance their careers in healthcare management without putting a strain on finances.

If you are aiming for the top clinical or leadership roles in nursing, cheapest dnp online programs provide a streamlined way to earn a Doctor of Nursing Practice while balancing personal and work commitments.

These online degree options expand your career pathways in medicine and healthcare, making advanced roles more accessible, flexible, and affordable.

Best Scientists Citing Mark A. Espeland

Trending Scientists

Recently Published Articles